• Publications
    Expected Returns Articles
  • Research
    Companies Funds Top 40 My Studies
  • Stock Screen
    New Stock Screen Manage Screens
  • Dashboards
    My Dashboards New Dashboard
  • Forum
  • Events
  • Search
  • Contact Us
  • Sign In

Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 80 17.7%
Current Price ( 3/22 4:00PM EDT) $138.46
CAPS Rating (Rate this stock on CAPS)
Expected Income Statement
Current Sales 3,659.4
Sales Growth Forecast 7.9%
Net Profit Margin 34.1%
Projected Shares Outstanding 70.06
EPS - Five year Forecast $26.06
Average P/E Ratio 12.0
Projected Average Price $312.76
Price Appreciation (Annualized) 17.7%
Annual Dividend Yield 0.0%
Projected Annual Return 17.7%
Quality
Financial Strength 98 24.5
EPS Stability 71 17.8
Industry Sales Growth Rate 15.0% 6.6
Industry Net Profit Margin 30.0% 14.2
Calculated Quality Rating 63.1
Fool CAPS

Total Players

284 Outperforms
66 Underperforms
 

All-Stars (60)

44 Outperforms (73%)
16 Underperforms
 
Fundamental Data Updated: 03/03/2023
MIPAR 12.3%  
Sweet Spot 17.3% - 22.3%  
Top In Biotechnology
Ticker Quality PAR
JAZZ 80 17.7%
CPRX 65 26.9%
XNCR 38 23.0%
UTHR 85 9.5%
INO 34 23.5%
Top In Healthcare
Ticker Quality PAR
AMED 87 18.6%
CVS 89 18.2%
BAX 77 23.5%
INMD 87 18.1%
STE 94 15.4%

© 2006 - 2023 Manifest Investing. All rights reserved.
About | Terms of Service | Disclaimer | Privacy Policy

Legend
Quality Legend:
Blue Excellent with quality greater than 80.
Green Good with quality between 60 and 80.
Neutral Average or below average with quality between 20 and 60.
Red Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow PAR is above the target range of MIPAR +10%, currently 10.1%
PAR Projected Annual Return
MIPAR The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
* Not covered by Value Line Standard Edition.
b Uses price-to-book value for valuation purposes.
P/CF Uses price-to-cash flow for valuation.